EUVIMEDEUVIMED entdecken
Crossref

Abstract FR537: Blood Pressure Control in Women With Hypertensive Disorders of Pregnancy and Chronic Hypertension on Combined Oral Contraceptives

Stephen Foley, Katherine A Sadaniantz, Grace Zhou, Minakshi Pillai, Lara Kovell

Hypertension · 2026-10 · 83 (Suppl_1)

DOI: 10.1161/hyp.83.suppl_1.fr537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Stephen Foley und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hypertensive disorders of pregnancy (HDPs) portend an elevated risk of future cardiovascular disease, including higher risk of developing chronic hypertension (HTN) up to twenty years postpartum. According to the 2024 US Medical Eligibility Criteria, combined oral contraceptives (COCs) are not recommended in persons with HTN, regardless of control, however, the benefits are thought to outweigh the risks in persons with HDPs. Research Question: The aim of this study was to determine blood pressure control among women of child-bearing age with history of HDP and chronic HTN on COCs after pregnancy.

Methods

This retrospective cohort study conducted a TriNetX database query of electronic medical records in the United States Collaborative Network of women aged 18-45 years on COCs with an index event of pregnancy with delivery from 2015-2020. Women who saw a PCP within 1 year of delivery were included. HDP was defined by ICD codes for gestational HTN, preeclampsia, and eclampsia. Chronic HTN was defined by ICD codes for essential or secondary HTN. Controls were those without HDP or chronic HTN. Data regarding race, ethnicity, and comorbidities were collected. Pairwise comparisons among the HDP, chronic HTN, and control groups were performed using Student's t-test.

Results

A total of 3,553 patients with HDPs on COCs, 2,410 patients with chronic HTN on COCs, and 23,985 control patients were identified (Table 1). A subset of these (67-88.5%) had systolic blood pressure (SBP) measurements available at 1 and 5 years postpartum. The chronic HTN group was slightly older and more likely to have co-existing type 2 diabetes mellitus, hyperlipidemia, and nicotine dependence, as compared to the HDP and control groups. At 1 year postpartum, 16.0% of patients with HDP on COCs met criteria for stage I HTN and 5.6% met criteria for stage II, which increased to 17.0% (stage I) and 8.6% (stage II) at 5 years (Table 2). Compared to the HTN group, the HDP group was significantly more likely to be normotensive and less likely to meet criteria for HTN at both time points. Notably, the HDP group was significantly more likely than the HTN group to have borderline SBP at 5 years (30.6% versus 27.0%, p < 0.05).

Conclusions

In our cohort, over half of women with HDP on COCs met criteria for borderline, stage I, or stage II HTN up to five years postpartum. Given the increased risk of developing chronic HTN after HDP, the use of COCs in this population should be cautioned. Future research should investigate early blood pressure screening and deprescription of COCs women with HDPs.

Zitieren

APA

Foley, S., Sadaniantz, K. A., Zhou, G., Pillai, M., & Kovell, L. (2026). Abstract FR537: Blood Pressure Control in Women With Hypertensive Disorders of Pregnancy and Chronic Hypertension on Combined Oral Contraceptives. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.fr537

Vancouver

Foley S, Sadaniantz KA, Zhou G, Pillai M, Kovell L. Abstract FR537: Blood Pressure Control in Women With Hypertensive Disorders of Pregnancy and Chronic Hypertension on Combined Oral Contraceptives. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.fr537

BibTeX
@article{Foley2026,
  author = {Foley, Stephen and Sadaniantz, Katherine A and Zhou, Grace and Pillai, Minakshi and Kovell, Lara},
  title = {Abstract FR537: Blood Pressure Control in Women With Hypertensive Disorders of Pregnancy and Chronic Hypertension on Combined Oral Contraceptives},
  journal = {Hypertension},
  year = {2026},
  volume = {83},
  number = {Suppl_1},
  doi = {10.1161/hyp.83.suppl_1.fr537}
}
Kostenlos starten →